Overview

Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the safety and efficacy of SPRC-AB01 versus placebo for treatment of chronic sinusitis in subjects who have had sinus surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Naryx Pharma